The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme cases. It affects tens ...

A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic ...

Good morning, and welcome to the Atea Pharmaceuticals Virtual KOL event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Atea website ...

The Hepatitis B and C Therapeutics Market has entered a renewed growth cycle in 2024, led by innovative antiviral regimens, ...

Chronic hepatitis C infection has been linked to a higher risk of pancreatic cancer. Learn more about findings from a major ...

The study provides strong evidence that chronic HCV infection increases the likelihood of developing PDAC, with certain ...

This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global ...

Diagnosed with hepatitis B about eight years ago and now in the cirrhosis stage (liver damage), the 49-year-old from Sabah admitted that he was initially disheartened before finding the strength to ...

Although treatment with direct acting antivirals reduced hepatic steatosis in patients with chronic hepatitis C and fatty ...